Additionally, in cancer patients, high levels of TRAIL expression are associated with longer overall survival, particularly in cases with high tumor macrophage content, suggesting that TRAIL enhances anti-tumor responses by promoting M1 macrophage polarization in the tumor microenvironment (Figure 4) (97). This evidence concerns the gene TNFSF10 and neoplasm.